ONE-SITE-STOP
Live / Registered — Registered (as of 01 Mar 2022)
What this means for you
Registered since 01 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79295861
- Registration number
- 6655646
- Mark type
- Stylized text
- Filed
- 02 Jun 2020
- Published for opposition
- 14 Dec 2021
- Registered
- 01 Mar 2022
- Attorney of record
- R Peter Spies
Goods and services
- Class 001 — Chemicals: Active chemical ingredients for use in the manufacture of pharmaceuticals for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
- Class 005 — Pharmaceuticals: Compositions for medical and veterinarian use, namely, chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals; diagnostic preparations for medical purposes; chemical products for pharmaceutical use, namely, chemical preparations for the prevention, diagnosis, treatment or improvement of conditions and disorders, namely, inflammatory, allergical, oncological, degenerative, genetic, traumatic, tumoural, pressure, poisoning, mutation, sepsis, psychiatric, obese, eating, addictive, sexual, sleep, and infectious conditions and disorders, namely, bacterial, viral, fungal or parasitic conditions and disorders, all of the above related to skin, musculo-skeletal, cardiac, neurological, cellular, vascular, hematological, respiratory, digestive, genital, urinary, reproductive, sensorial, metabolic, endocrine, lymphatic, immune or nervous systems, as well as pain management, for use by humans or animals
- Class 042 — Scientific and technological services: Development of pharmaceutical products and drug products; research on pharmaceutical products and drug products; research and development of new products in the pharmaceutical industry; consulting services in the field of design and development of engineering processes for the pharmaceutical industry; research and development services in the pharmaceutical field; research and development services in the field of pharmaceuticals, chemical preparations, vaccines, medicines, antibodies, new products in the medical field
Owner
Prosecution history
- 26 Jun 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 18 Sept 2022 — NEW REPRESENTATIVE AT IB RECEIVED
- 22 Aug 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 03 Aug 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 03 Aug 2022 — FINAL DISPOSITION PROCESSED
- 01 Jun 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 01 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 19 Dec 2021 — NOTIFICATION PROCESSED BY IB
- 14 Dec 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 Dec 2021 — PUBLISHED FOR OPPOSITION
- 24 Nov 2021 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 24 Nov 2021 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 24 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 09 Nov 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Nov 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED